LHDX
Price:
$0.4523
Market Cap:
$18.36M
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.[Read more]
Industry
Medical - Devices
IPO Date
2021-02-04
Stock Exchange
NASDAQ
Ticker
LHDX
According to Lucira Health, Inc.’s latest financial reports and current stock price. The company's current ROE is -102.50%. This represents a change of 88.36% compared to the average of -54.42% of the last 4 quarters.
The mean historical ROE of Lucira Health, Inc. over the last ten years is 24.33%. The current -102.50% ROE has changed -521.29% with respect to the historical average. Over the past ten years (40 quarters), LHDX's ROE was at its highest in in the December 2020 quarter at 27.58%. The ROE was at its lowest in in the September 2022 quarter at -208.35%.
Average
24.33%
Median
35.81%
Minimum
-34.34%
Maximum
60.03%
Discovering the peaks and valleys of Lucira Health, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 80.04%
Maximum Annual ROE = 60.03%
Minimum Annual Increase = -157.20%
Minimum Annual ROE = -34.34%
Year | ROE | Change |
---|---|---|
2021 | -34.34% | -157.20% |
2020 | 60.03% | 80.04% |
2019 | 33.34% | -12.91% |
The current ROE of Lucira Health, Inc. (LHDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.68%
5-year avg
24.33%
10-year avg
24.33%
Lucira Health, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lucira Health, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lucira Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Lucira Health, Inc.'s ROE?
How is the ROE calculated for Lucira Health, Inc. (LHDX)?
What is the highest ROE for Lucira Health, Inc. (LHDX)?
What is the 3-year average ROE for Lucira Health, Inc. (LHDX)?
What is the 5-year average ROE for Lucira Health, Inc. (LHDX)?
How does the current ROE for Lucira Health, Inc. (LHDX) compare to its historical average?